Trizivir

Active Ingredient(s): Abacavir + Lamivudine, 3TC + Zidovudine, ZDV
FDA Approved: * November 14, 2000
Pharm Company: * GLAXOSMITHKLINE
Category: HIV / AIDS

Abacavir/lamivudine/zidovudine, sold under the brand name Trizivir, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS.[2][3][4] It contains three reverse transcriptase inhibitors patented by GlaxoSmithKline and marketed by a joint venture with Pfizer, ViiV Healthcare:[5] abacavir sulfate (ABC) lamivudine (3TC) zidovudine (AZT or ZDV) It is indicated in the treatment of AIDS/HIV-1.[2&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Trizivir GX;LL1
Trizivir (Abacavir 300 mg / Lamivudine 150 mg / Zidovudine 300 mg) Oral Tablet
NDC: 49702-217
Labeler:
Viiv Healthcare Company
Trizivir GX;LL1
Trizivir Oral Tablet, Film Coated
NDC: 53808-0990
Labeler:
State of Florida Doh Central Pharmacy